Pharmac Decision: Silver diamine fluoride to be funded from 1 December

Pharmac Decision: Silver diamine fluoride to be funded from 1 December

Pharmac has confirmed it will fund silver diamine fluoride for people accessing dental services through public hospitals, and the ‘Health New Zealand Community Oral Health Service’ for children and some adolescents.

This decision follows recent consultation and is expected to benefit children, elderly patients, and those who may find some traditional dental procedures challenging.

Silver diamine fluoride is a topical dental treatment, combining ionic silver and fluoride. It can stop the progression of existing cavities and reduce tooth sensitivity. It is used in hospitals and community dental clinics and can only be administered by a registered oral health practitioner.

You can read the full decision and summary of feedback on our website

Thank you to all those who provided feedback in response to our consultation. Your input is invaluable in helping us make well-informed decisions.

Ngā mihi,

John Lowe | Therapeutic Group Manager

Pharmac | Te Pātaka Whaioranga | P: 0800 660 050 | www.pharmac.govt.nz